2 0 2 4年第四季度，赛莱默实现营收2 3亿美元 ， 按报告数据及有机增长计算均增长7%；订单 额达2 2亿美元，按报告数据及有机增长计算均增长 7%；每股收益为1 . 3 4美元，增长2 2%；调 整后每股收益为1 . 1 8美元，增长1 9%。 导读： 2025 年2月4日，赛莱默公司公布了2024年第四季度及全年业绩，2024年全年营收达到86亿美 元，同比增长16%。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 2 0 2 5 年2月4日，赛莱默公司（纽约证券交易所代码：XYL）公布了2 0 2 4年第四季度及全年业 绩。凭借强大的执行力和市场需求，赛莱默在2 0 2 4年第四季度总营收达2 3亿美元，净利润为 3 . 2 6亿美元。2 0 2 4年全年营收达到8 6亿美元，按报告数据计算，同比增长1 6%。 | (in millions, except per share data) | 2024 | | | 2023 | | | --- | --- | --- | --- | --- | --- | | Net inc ...

Core Insights - The company reported a relatively flat global insurance volume year-over-year, with a nominal decline of 0.3% in unit sales globally and 0.9% in the United States [5]. Group 1: Insurance Business Performance - Global insurance unit sales grew by 1.3% when accounting for the extra business day in leap year 2024, while U.S. insurance units sold increased by 0.6% [5]. - Total loss frequency continues to rise, indicating potential challenges in the insurance sector [5]. Group 2: Financial Performance Overview - The CEO, Jeff Liaw, highlighted the preparation for the 2025 catastrophe season, indicating proactive measures being taken by the company [4].

关于卧龙新能源集团股份有限公司 财务业绩真实性和会计处理合规性 的专项核查说明 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中兴华会计师事务所（特殊普通合伙） ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地 址 （ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 20 层 电 话 （ t e l ）： 0 1 0 - 5 1 4 2 3 8 1 8 传 真 （ f a x ）： 0 1 0 - 5 1 4 2 3816 关于卧龙新能源集团股份有限公司 财务业绩真实性和会计处理合规性 的专项核查说明 中兴华核字（2025）510008 号 上海证券交易所： 根据中国证券监督管理委员会发布的《监管规则适用指引--上市类第 1 号》之"1-11 上市公司重组前业 ...

Financial Data and Key Metrics Changes - In Q1 2025, the company achieved a net profit with an 87% improvement in gross margin compared to Q1 2024 [5] - Adjusted EBITDA in Q1 2025 resulted in a profit of $600,000, an improvement of almost $3,000,000 from an adjusted EBITDA loss of $2,200,000 in Q1 2024 [8] - Revenues for Q1 2025 were $12,500,000, a 4% increase from $12,100,000 in Q1 2024, primarily driven by growth in Germany [8][10] - Gross profit for Q1 2025 was $3,400,000, a 94% increase from $1,800,000 in Q1 2024 [10] - Net profit for Q1 2025 was approximately $200,000, compared to a loss of $6,000,000 in Q1 2024, marking a $6,200,000 improvement [11] Business Line Data and Key Metrics Changes - The German business grew by 569% compared to Q1 2024, significantly offsetting a 66% revenue decline in Israel [6][8] - The company launched 12 new strains in Germany, contributing approximately €3,000,000 or 39% of cannabis flower sales in that market [5] - The decline in Israeli revenue was attributed to the cancellation of the Orenin deal, resulting in a decrease of approximately $3,500,000 compared to Q1 2024 [9] Market Data and Key Metrics Changes - Germany's share of total revenue in Q1 2025 increased to 62%, reflecting favorable market conditions and growing demand [9] - The cost of revenue decreased by 12% to $9,100,000 in Q1 2025, down from $10,300,000 in Q1 2024 [9] Company Strategy and Development Direction - The company is focusing on execution and resource allocation to areas with the highest return on investment (ROI) [5] - The strategic shift towards the German market is evident, with significant growth in that region while managing operational efficiencies [6][8] Management's Comments on Operating Environment and Future Outlook - Management expressed pride in the team's efforts and noted that the efficiencies and integration from the past two years are starting to reflect in financial results [6][11] - The company aims to continue executing its strategy and maintain profitability moving forward [7] Other Important Information - Total assets as of March 31, 2025, were $44,934,000, an increase of 15% from $39,188,000 as of December 31, 2024 [11] - Total liabilities increased by 16% to $41,761,000 as of March 31, 2025, compared to $36,042,000 as of December 31, 2024 [12] Q&A Session Summary Question: Importance of the upcoming meeting for accepting 25% ownership of Focus - Management indicated that this is a long process on the regulatory side and is crucial for clearing balances between companies and moving long-term loans to equity [17][18] - The need to hold 100% of the Focus shares is based on tax regulations to avoid issues with tax authorities [19]

Veteran health insurance broker SelectQuote (SLQT -12.17%) wasn't quite looking like the wave of the future on Monday. The company's shares took a 12% hit on the day, following management's release of the latest set of quarterly figures. That was in rather sharp contrast to the overall stock market, where the benchmark S&P 500 index rose by a relatively steep 3.3%.Healthy growth, but a bottom-line missFor its fiscal third quarter of 2025, SelectQuote reaped just over $408 million in total revenue, up from t ...

Core Viewpoint - Allegro MicroSystems, Inc. reported better-than-expected fourth-quarter financial results and provided first-quarter sales guidance above market estimates [1][2]. Financial Performance - The company posted adjusted earnings of $0.06 per share, surpassing market expectations of $0.05 per share [1][2]. - Quarterly sales reached $192.82 million, exceeding expectations of $185.28 million, representing an 8% sequential increase [1][2]. Future Guidance - For the first quarter, Allegro expects adjusted earnings between $0.06 and $0.10 per share, with sales projected between $192 million and $202 million [2]. Market Reaction - Following the earnings announcement, Allegro MicroSystems shares increased by 12.7%, closing at $21.07 [3]. Analyst Ratings - Needham analyst Quinn Bolton maintained a Buy rating on Allegro, lowering the price target from $30 to $25 [8]. - Barclays analyst Blayne Curtis maintained an Overweight rating, raising the price target from $22 to $23 [8].

Diversified Healthcare Trust (DHC) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Company Participants Matt Murphy - Manager-Investor RelationsChris Bilotto - President & CEOAnthony Paula - Vice PresidentMatthew Brown - CFO & TreasurerJustin Haasbeek - Senior Associate, Equity Research Conference Call Participants John Massocca - Senior Research Analyst Operator Good morning and welcome to Healthcare Trust First Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mod ...

Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Michelle Esterman - Chief Financial Officer William Shepro - Chairman and Chief Executive Officer Conference Call Participants Ramin Kamali - Credit Suisse Robert Heimowitz - Concise Capital Operator Good day, and thank you for standing by. Welcome to the Altisource Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the s ...

证券研究报告|行业研究报告 [Table_Title2] 有色金属-海外季报 [Table_Summary] 季报重点内容: ►2024Q4 生产经营情况（Metals X 持有 Renison 50%股份， 除非有特殊说明，均为 100%基准） 1）产量 2024Q4 Renison 锡精矿总产量达 3,329 吨，创下锡产量最 高季度纪录，环比增长 15%，同比增长 23%（2024Q3：锡精 矿产量 2,899 吨），这一里程碑的取得得益于地下矿山开采数 量和品位的提高，以及工厂内各种提高回收率和吞吐能力计划 的持续实施。 [Table_Date] 2025 年 3 月 3 日 Metals X 通过其在 Bluestone Mines Tasmania 合资企业 (BMTJV) 中持有的 50% 股份，拥有 Renison 锡矿 50%的股 权，Metals X 2024Q4 权益产量为 1665 吨锡精矿，环比增长 15 %，同比增长 15%。 2）出货量 Renison 2024Q4 锡精矿出货量为 3,132 吨，环比持平，同 比增长 19.5%。Metals X 在本季度锡精矿出货量占比为 5 ...

凯士比集团首席执行官 Stephan Timmermann 博士 "尽管欧洲的经济形势依旧严峻且全球政治局势紧张，我们对 2024 财年的业绩感到 非常满意 ｡尤其是第四季度的出色表现，使 2024 年 成为凯士比 迄今为止历史上最成功的一年｡ " 在 2024 年 1 月至 12 月期间， 凯士比的订单增长 5.2%, 达到 31.14 亿欧元 (上一年度为 29.6 亿欧元), 其中 2024 年第四季度的订单量为 7.3 亿欧元 (+15.8%)｡ 凭借 强劲的备件业务 ，特别是在能源 (+11.7%) 和通用工业 (+8.7%) 市场领域， 凯士比卓越服务业务板块实现了最大幅度的增长 ，增长 5.8% , 达到 10.48 亿欧元 (上一年度为 9.9 亿欧元)｡ 泵业务板块的订单增长 5.2% , 达到 16.59 亿欧元 (上一年度为 15.76 亿欧元)｡这一增长主要归功于能源市场面 (+15.8%, 达到 2.32 亿欧元) 和水市场面 (+13.7%, 达到 4.94 亿欧元) 的主要订单｡与上一年度因获得大额订单而受益不同，矿业市场面新泵的订单量同比下降了 19.2%, 降至 9100 万 ...